Dr. Sujani Yadlapati, MD

Dr. Yadlapati practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Yadlapati's NPI, 1689023616, was assigned on June 9, 2016. Dr. Yadlapati holds Indiana license 01089520A.

Dr. Yadlapati's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Yadlapati's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Yadlapati is also affiliated with Union Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Yadlapati to 1 more hospital, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yadlapati practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Yadlapati's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Yadlapati's licenses on file in 2 states: Indiana and Pennsylvania.

CMS data shows 109 Medicare services from Dr. Yadlapati across 6 procedure codes in 2024, for 88 Medicare patients. Medicare paid $9,577 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Dr. Yadlapati in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yadlapati's median patient age at 59, with 53% women.

In 2024, Dr. Yadlapati wrote 23 Medicare Part D claims for 17 patients. 91% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $133 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

Dr. Yadlapati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 230 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Yadlapati, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 16 papers to Dr. Yadlapati, published from 2015 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Autoimmune Diseases, Cholestasis and Inflammation. Dr. Yadlapati has published most often in Cureus. Dr. Yadlapati's most frequent co-authors are Vincent Michael Figueredo, MD, Abhinav Goyal, MD and Thomas A. Judge, MD.

CMS Open Payments shows 59 general payments to Dr. Yadlapati from 12 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 51% of the total. Boston Scientific Corporation paid the most, $4,517.